QMS Medical Allied Services IPO Details & Guidance

Grey Market News for QMS Medical Allied Services IPO #
On 11 October 2022, click

QMS Medical Allied Services IPO Subscription Status
On 30 September 2022 @ 5.00 pm
HNI 50%22,32,000 Shares: 1.25T
RII 50%  22,32,000 Shares: 0.51T
Tot 44,64,000 Shares:        0.88T

QMS Medical Allied Services IPO Details
IPO Dates   27-09-2022 to 30-9-2022
Face Value  Rs 10 per share
IPO Price    Rs 121 per share
Lot             1000 Shares
Issue Size  47,00,000 shares of Rs 10
Issue           Rs 56.87 Cr)
# Fresh Issue 28,00,000 shares of Rs 10/Rs 33.88 Cr
# Offer for Sale 19,00,000 shares of Rs 10/ Rs 22.99 Cr
Issue Type Book Built IPO
Listing At NSE SME
Objects of the IPO
Funding additional Working capital requirements

Retail Offer: 50 % / 22,32,000 Shares
RII Min. Application: 1000 Shares, Rs. 121,000
RII Max. Application: 1000 Shares, Rs. 121,000
2232 Applications required for onetime RII-subscriptions.

QMS Medical Allied Services IPO Timetable 
IPO Opening Date: September 27, 2022
IPO Closing Date: September 30, 2022
Basis of Allotment: October 06, 2022
Initiation of Refunds: October 07, 2022
Credit of Shares to Demat A/cs: October 10, 2022
IPO Listing Date: October 11, 2022

QMS Medical Allied Services Business:

The Company is engaged in the marketing and distribution of a wide range of medical and healthcare devices and accessories. It markets and distributes these products to various end users such as clinics, pharma and medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and also under our own brand. It has recently launched its brand “Q-Devices” with an intention to provide affordable and quality products in the market so as to become a customer preferred medical device company. It gets its products manufactured in India from third party manufacturers, under our own brand.

It markets and sells them under our own brand “Q-Devices”. The products sold under “Q-Devices” are affordable without compromising on the quality. It already has products such as glucometer, pulse oximeter, IR thermometer, BP Monitor, Anatomy set, Neurology kit, Orthopedic Aids and Weighing Scales.

It markets and helps in distribution of the products across India through offline and online mode by means of its own website The Company also offers a range of evidence-based, scientific content medical programs, which are used in updating“clinical knowledge and practices. Continuing medical education (CME) is a valuable mechanism to update physicians“knowledge with ever-increasing plethora of contemporary advances within medical fraternity

For more information about the company, Click Website: www.qmsmas.com

Service: To monetize their ad inventory of web channels
Promoters of QMS Medical Allied Services
MAHESH MAKHIJA

Registered office of QMS Medical Allied Services
A1 A2/B1 B2, Navkala Bharti Building, Plot No16, Prabhat Colony, Near Santacruz Bus Depot, Santacruz East, Mumbai-400055, Maharashtra, India
Company Secretary and Compliance Officer: Mrs. Savita Rana

Lead Manager of QMS Medical Allied Services
First Overseas Capital Ltd

SME IPO Financial & Analytical Ratios#
Total Income 2019-20             Rs 72.78 Cr
Total Income 2020-21             Rs 122.09 Cr
Total Income 2021-22             Rs 106.96 Cr(9M)
Net Profit 2019-20                  Rs 6.36 Cr
Net Profit 2020-21                  Rs 10.93 Cr
Net Profit 2021-22                  Rs 5.88 Cr (9M)
Earnings per Share 2019-20   Rs 0.86
Earnings per Share 2020-21   Rs 6.40
Earnings per Share 2021-22   Rs 8.84 (9M)
Return on Net Worth: 19-20: 1.71 %
Return on Net Worth: 20-21: 16.84 %
Return on Net Worth: 21-22: 27.30 % (9M)
Book Value of the Share as on 31.12.21 Rs 17.43
NAV after the IPO Rs. 33.67
Offer Price Rs. 121

IPO Peer Comparison:
The Company believes that none of the listed companies in India offer products or services across the various business segments in which it operates. Hence a strict comparison is not possible.

Observation by Paresh Gordhandas (Research Analyst)

Will update soon.

# This is only coverage of News related to Grey Market. We do not deal in grey market premium or Subject to rates, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.